Predict your next investment

HEALTHCARE | Drug Development
novmeta.com

See what CB Insights has to offer

Founded Year

2010

Stage

IPO | IPO

Date of IPO

10/1/2015

About NovMetaPharma

NovMetaPharma (KONEX: 229500) is a pharmaceutical company focused on the development of new drugs for metabolic diseases. The company aims to introduce therapeutic agents for osteoporosis, non-alcoholic fatty liver disease, and immune system diseases.

NovMetaPharma Headquarter Location

13F Trees Building 727 Eonju-ro, Gangnam-gu

Seoul, 06050,

South Korea

+82-2-538-1893

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NovMetaPharma Patents

NovMetaPharma has filed 11 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Diabetes
  • Autosomal recessive disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/13/2017

2/16/2021

Antineoplastic drugs, Rare diseases, Neurotrauma, Food ingredients, Hepatotoxins

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/13/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/16/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Antineoplastic drugs, Rare diseases, Neurotrauma, Food ingredients, Hepatotoxins

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

NovMetaPharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NovMetaPharma Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.